Status: current, Defined. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3745104011 | Product containing only fremanezumab in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3745105012 | Fremanezumab only product in parenteral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Fremanezumab only product in parenteral dose form | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Fremanezumab only product in parenteral dose form | Is a | Fremanezumab-containing product in parenteral dose form | true | Inferred relationship | Some | ||
| Fremanezumab only product in parenteral dose form | Is a | Fremanezumab only product | true | Inferred relationship | Some | ||
| Fremanezumab only product in parenteral dose form | Has active ingredient | Fremanezumab | true | Inferred relationship | Some | 1 | |
| Fremanezumab only product in parenteral dose form | Plays role | Antimigraine therapeutic role | true | Inferred relationship | Some | ||
| Fremanezumab only product in parenteral dose form | Has manufactured dose form | Parenteral dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Fremanezumab 150 mg/mL solution for injection | Is a | True | Fremanezumab only product in parenteral dose form | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set
FHIR